1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Switzerland >
  5. iOncologi Acquires TargImmune Therapeutics

M&A Deal Summary

iOncologi Acquires TargImmune Therapeutics

On March 14, 2025, iOncologi acquired life science company TargImmune Therapeutics

Acquisition Highlights
  • This is iOncologi’s 1st transaction in the Life Science sector.
  • This is iOncologi’s 1st transaction in Switzerland.

M&A Deal Summary
Date 2025-03-14
Target TargImmune Therapeutics
Sector Life Science
Buyer(s) iOncologi
Deal Type Add-on Acquisition

Target

TargImmune Therapeutics

Basel, Switzerland
TargImmune Therapeutics is a biotechnology company developing targeted immunotherapy solutions designed to enhance anti-tumor immune responses. TargImmune Therapeutics was founded in 2016 and is headquartered in Basel, Switzerland.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

iOncologi

Gainesville, Florida, United States
Category Company
Sector Life Science
DESCRIPTION

iOncologi is a clinical-stage biopharmaceutical company dedicated to developing innovative immunotherapies for the treatment of solid tumors. The company focuses on harnessing the power of the immune system to create next-generation oncology treatments that improve patient outcomes. iOncologi is headquartered in Gainesville, Florida.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Switzerland M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal